We are really proud to spotlight our ongoing collaboration with Pierre Fabre, a leading global healthcare company combining world-class pharmaceutical innovation and dermo-cosmetic expertise. Based in France and owned largely by the Pierre Fabre Foundation, Pierre Fabre Laboratories excels in oncology, dermatology, rare diseases, and more.

At INITS, we have been supporting Pierre Fabre’s drug development efforts in Drug Product particularly in development and validation. Here’s what Thomas BALLET, Director of Pharmaceutical Development at Pierre Fabre, shared about our partnership:

« Working with INITS consultants has been a truly rewarding experience. Their deep expertise, particularly in Drug Product development and validation, has been instrumental in keeping our biological drug project on track for regulatory submission. They’ve provided strong leadership and structure, especially on validation activities. We’ve recently extended our collaboration to include Drug Substance, Analytics, and Secondary Packaging, reflecting the trust we've built. Their agility, exceptional report quality, and strategic positioning in managing our subcontractors, combined with transparent communication and adaptability to our constraints and timelines, make them a highly valuable partner. »

This expansion of our collaboration — from Drug Product to Drug Substance, Analytics, and Secondary Packaging — underscores the trust and value Pierre Fabre places in INITS.

We look forward to continuing this journey, contributing to their projects, and maintaining the high standards that drive real impact.